Virtu Financial LLC Uro Gen Pharma Ltd. Transaction History

Virtu Financial LLC

  • $1.31 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 30, 2018
SELL
$48.35 - $65.33 $651,999 - $880,975
-13,485 Closed
0 $0
Q2 2018

Jul 30, 2018
BUY
$48.35 - $65.33 $282,750 - $382,049
5,848 Added 76.57%
13,485 $671,000
Q1 2018

May 14, 2018
BUY
$38.64 - $57.54 $295,093 - $439,432
7,637 New
7,637 $379,000

Others Institutions Holding URGN

# of Institutions
113
Shares Held
24M
Call Options Held
46.9K
Put Options Held
44.3K
View Full List

About UroGen Pharma Ltd.

URGN Quotes by TradingView
  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $373M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email